Enzyme-Triggered Charge and Conformation Switching for Tumor-Selective Peptide–Drug Conjugates
Journal of Medicinal Chemistry · 28.05.2026 · 69 (10) · 12417-12429
DOI: 10.1021/acs.jmedchem.6c00326 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 16.05.2026. Verfasst von Jiaying Wei und 7 weiteren Autor:innen. Beteiligte Einrichtung: Hunan Provincial Key Laboratory of Animal Models and Molecular Medicine, State Key Laboratory of Chemo/bio-Sensing and Chemometrics, School of Biomed…. Hauptthemen laut MEDLINE: Cell-Penetrating Peptides, Camptothecin, Antineoplastic Agents, gamma-Glutamyltransferase. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: Natural Science Foundation of Hunan Province, Science and Technology Foundation of Shenzhen City, National Natural Science Foundation of China.
Abstract (Originalsprache)
Functionalizing anticancer drugs with activatable peptides offers a versatile strategy to achieve tumor-selective delivery while minimizing systemic toxicity. Here, we report a γ-glutamyltransferase (GGT)-responsive cell-penetrating peptide (P-EE) generated by γ-glutamyl masking of penetratin for tumor-selective activation in hepatocellular carcinoma. Upon GGT-mediated cleavage, P-EE restores its cationic charge and helical conformation, enabling efficient membrane translocation and selective accumulation in GGT-overexpressing tumor cells. P-EE showed enhanced internalization and approximately 5-fold higher cytotoxic potency in HepG2 cells compared with NHDF normal cells. Covalent conjugation of camptothecin (CPT) to P-EE yielded a peptide-drug conjugate (CPT-P-EE) with greatly improved aqueous solubility, potent antitumor activity, and over 50-fold reduced toxicity to normal cells. In vivo, CPT-P-EE significantly suppressed tumor growth and prolonged survival without inducing systemic toxicity. This study establishes a generalizable enzyme-activatable peptide-drug conjugate platform that integrates conformational switching with targeted delivery, offering a promising direction for precision chemotherapy against GGT-positive malignancies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Hunan Provincial Key Laboratory of Animal Models and Molecular Medicine, State Key Laboratory of Chemo/bio-Sensing and Chemometrics, School of Biomedical Science, Hunan University, Changsha, Hunan 410082, China.
- Department of Cardiology, The Central Hospital of Xiangtan (The Affiliated Hospital of Hunan University), Xiangtan, Xiangtan, Hunan 411100, China.
- Shenzhen International Institute for Biomedical Research, Shenzhen 518116, China.
- Shenzhen Research Institute Hunan University, Shenzhen, Guangdong 518000, China.
ORCID-Profile: Qipeng Yan, Yuan Dan, Xia Wu, Junfeng Shi
Förderung
- Natural Science Foundation of Hunan Province
- Science and Technology Foundation of Shenzhen City
- National Natural Science Foundation of China
- Natural Science Foundation of Guangdong Province
Zitieren
APA
Wei, J., Yan, Q., Jiang, X., Xie, W., Wei, M., Dan, Y., Wu, X., & Shi, J. (2026). Enzyme-Triggered Charge and Conformation Switching for Tumor-Selective Peptide–Drug Conjugates. Journal of Medicinal Chemistry, 69(10), 12417-12429. https://doi.org/10.1021/acs.jmedchem.6c00326
Vancouver
Wei J, Yan Q, Jiang X, Xie W, Wei M, Dan Y, et al. Enzyme-Triggered Charge and Conformation Switching for Tumor-Selective Peptide–Drug Conjugates. Journal of Medicinal Chemistry. 2026;69(10):12417-12429. doi:10.1021/acs.jmedchem.6c00326
BibTeX
@article{Wei2026,
author = {Wei, Jiaying and Yan, Qipeng and Jiang, Xingyue and Xie, Wei and Wei, Min and Dan, Yuan and Wu, Xia and Shi, Junfeng},
title = {Enzyme-Triggered Charge and Conformation Switching for Tumor-Selective Peptide–Drug Conjugates},
journal = {Journal of Medicinal Chemistry},
year = {2026},
volume = {69},
number = {10},
pages = {12417--12429},
doi = {10.1021/acs.jmedchem.6c00326}
}
EUVIMED